The Curious Case of FGFR1

It is well accepted that one of the most important breakthroughs is breast cancer research in terms of its impact on the treatment of patients

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In
   
New User Registration
*Required field
Powered by WP-Members

About Steve Ethier

Professor, Department of Pathology and Laboratory Medicine, MUSC. I am the developer of the SUM breast cancer cell lines, and the SUM Line Knowledge Basse

View all posts by Steve Ethier →